KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Other financing activities (2019)

Historic Other financing activities for Arbutus Biopharma (ABUS) over the last 7 years, with Q3 2019 value amounting to $18.5 million.

  • Arbutus Biopharma's Other financing activities changed N/A to $18.5 million in Q3 2019 from the same period last year, while for Dec 2019 it was $18.5 million, marking a year-over-year change of. This contributed to the annual value of $18.5 million for FY2019, which is N/A changed from last year.
  • Arbutus Biopharma's Other financing activities amounted to $18.5 million in Q3 2019.
  • In the past 5 years, Arbutus Biopharma's Other financing activities ranged from a high of $28.6 million in Q1 2015 and a low of $18.5 million during Q3 2019